The mark consists of a design of comprised of two blue, curved lines forming an arrow shape which points up and towards the left, above a red chevron shape made of numerous shaded red triangles and diamonds, which points down and towards the right.
Mark For: This trademark registration is intended to cover the categories of
>The color blue and red are claimed as a feature of the mark. The mark consists of a design of comprised of two blue, curved lines forming an arrow shape which points up and towards the left, above a red chevron shape made of numerous shaded red triangles and diamonds, which points down and towards the right.
Research | OneLook Acronym Finder |
Serial Number | 79306375 |
Registration Number | 6635130 |
Mark Literal Elements | None |
Mark Drawing Type | 2 - AN ILLUSTRATION DRAWING WITHOUT ANY WORDS(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2022-02-08 |
Basis | 66(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | Yes |
Current Basis | No |
No Basis | No |
2020-12-10 | Application Filed |
2021-03-11 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-03-11 | Status: Live/Pending |
2021-03-19 | Transaction Date |
2021-11-23 | Published |
2022-02-08 | Location: PUBLICATION AND ISSUE SECTION |
2022-02-08 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2022-02-08 | Trademark Registered |
2027-02-08 | Maintenance Early File Date |
2028-02-08 | Maintenance On Time Date |
2028-08-08 | Maintenance Late Fee Date |
Party: | Otsuka Pharmaceutical Co., Ltd. |
Address | 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo 101-8535 JAPAN |
Legal Entity Type | Corporation |
Legal Entity State | JAPAN |
Application | 2021-03-11 | |
Drawing | 2021-03-11 | |
Filing Receipt Trademark Application | 2021-03-23 | |
Notation to File | 2021-06-16 | |
Offc Action Outgoing | 2021-06-16 | |
XSearch Search Summary | 2021-06-16 | |
IB-1rst Refusal Note | 2021-06-24 | |
IB-Processed Transaction | 2021-07-08 | |
Response to Office Action | 2021-10-12 | |
Amendment and Mail Process Complete | 2021-10-14 | |
TRAM Snapshot of App at Pub for Oppostn | 2021-10-21 | |
Notice of Publication | 2021-11-03 | |
Notification Of Notice of Publication | 2021-11-03 | |
IB-Opposition Notice To | 2021-11-17 | |
OG Publication Confirmation | 2021-11-23 | |
IB-Processed Transaction | 2021-12-02 | |
Registration Certificate | 2022-02-08 | |
IB-Final Disposal To | 2022-07-15 | |
IB-Processed Transaction | 2022-08-04 |
26.05.16 | Triangles touching or intersecting |
26.05.21 | Triangles that are completely or partially shaded |
26.17.09 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
260515 | Four or more triangles; Triangles |
260516 | Triangles touching or intersecting |
260521 | Triangles that are completely or partially shaded |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations being biological preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use
IC 040. US 100 103 106. G & S: Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals
IC 044. US 100 101. G & S: Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells for medical purposes
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 40 |
U.S. Codes: | 100,103,106 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | The color(s) blue and red is/are claimed as a feature of the mark. |
GS0401 | Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals |
Description | Date | Proceeding Number |
---|---|---|
FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-08-09 | |
FINAL DISPOSITION NOTICE SENT TO IB | 2022-07-16 | |
FINAL DISPOSITION PROCESSED | 2022-07-15 | 70029 |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-05-08 | |
REGISTERED-PRINCIPAL REGISTER | 2022-02-08 | |
NOTIFICATION PROCESSED BY IB | 2021-12-06 | |
PUBLISHED FOR OPPOSITION | 2021-11-23 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-23 | |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-11-17 | |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-11-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-11-03 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-10-20 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-10-13 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-10-12 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-10-12 | 88889 |
REFUSAL PROCESSED BY IB | 2021-07-11 | |
REFUSAL PROCESSED BY MPU | 2021-06-24 | 72629 |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-06-24 | |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-06-17 | |
NON-FINAL ACTION WRITTEN | 2021-06-16 | 93922 |
ASSIGNED TO EXAMINER | 2021-06-02 | 93922 |
APPLICATION FILING RECEIPT MAILED | 2021-03-23 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-03-19 | |
LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2021-03-18 | 67445 |
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-03-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.